Research Article| Volume 45, ISSUE 6, P1017-1027, April 2009

The advantage of women in cancer survival: An analysis of EUROCARE-4 data

Published:December 24, 2008DOI:


      We analysed 1.6 million population-based EUROCARE-4 cancer cases (26 cancer sites, excluding sex-specific sites, and breast) from 23 countries to investigate the role of sex in cancer survival according to age at diagnosis, site, and European region. For 15 sites (salivary glands, head and neck, oesophagus, stomach, colon and rectum, pancreas, lung, pleura, bone, melanoma of skin, kidney, brain, thyroid, Hodgkin disease and non-Hodgkin’s lymphoma) age- and region-adjusted relative survival was significantly higher in women than men. By multivariable analysis, women had significantly lower relative excess risk (RER) of death for the sites listed above plus multiple myeloma. Women significantly had higher RER of death for biliary tract, bladder and leukaemia. For all cancers combined women had a significant 5% lower RER of death. Age at diagnosis was the main determinant of the women’s advantage, which, however, decreased with increasing age, becoming negligible in the elderly, suggesting that sex hormone patterns may have a role in women’s superior ability to cope with cancer.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Trussell J.
        Women’s longevity.
        Science. 1995; 270: 719-720
        • Culic V.
        • Miric D.
        • Jukic I.
        Acute myocardial infarction: differing preinfarction and clinical features according to infarct site and gender.
        Int J Cardiol. 2003; 90: 189-196
        • McArdle C.S.
        • McMillan D.C.
        • Hole D.J.
        Male gender adversely affects survival following surgery for colorectal cancer.
        Br J Surg. 2003; 90: 711-715
        • Ohnishi T.
        • Oishi Y.
        • Goto H.
        • Yanada S.
        • Abe K.
        Gender as a prognostic factor in patients with renal cell carcinoma.
        BJU Int. 2002; 90: 32-36
        • Baldursson G.
        • Agnarsson B.A.
        • Benediktsdottir K.R.
        • Hrafnkelsson J.
        Soft tissue sarcomas in Iceland 1955–1988. Analysis of survival and prognostic factors.
        Acta Oncol. 1991; 30: 563-568
        • Micheli A.
        • Mariotto A.
        • Giorgi R.A.
        • Gatta G.
        • Muti P.
        The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group.
        Eur J Cancer. 1998; 34: 2271-2278
        • Verbrugge L.M.
        Sex differentials in health.
        Public Health Rep. 1982; 97: 417-437
      1. Table available from the EUROCARE web-site <> accessed 03.04.08].

        • De Angelis R.
        • Francisci S.
        • Baili P.
        • et al.
        • the EUROCARE Working Group
        The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis.
        Eur J Cancer. 2009; 45: 909-930
        • Berrino F.
        • The EUROCARE Working group
        Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study.
        The Lancet Oncology. 2007; 8: 773-783
        • Fritz A.
        • Percy C.
        • Jack A.
        • et al.
        WHO International classification of diseases for oncology.
        3rd ed. WHO, Geneva2000
        • Johnson K.C.
        • Pan S.
        • Mao Y.
        Canadian Cancer Registries Epidemiology Research Group. Risk factors for male breast cancer in Canada, 1994–1998.
        Eur J Cancer Prev. 2002; 11: 253-263
        • Corazziari I.
        • Quinn M.
        • Capocaccia R.
        Standard cancer population for estimating age standardising survival ratios.
        Eur J Cancer. 2004; 40: 2307-2316
        • Brown C.C.
        The statistical comparison of relative survival rates.
        Biometrics. 1983; 39: 941-948
        • Hakulinen T.
        Cancer survival corrected for heterogeneity in patient withdrawal.
        Biometrics. 1982; 38: 933-942
        • Dickman P.W.
        • Sloggett A.
        • Hills M.
        • Hakulinen T.
        Regression models for relative survival.
        Statistics in Medicine. 2004; 23: 51-64
      2. Surveillance Research Program, National Cancer Institute SEER∗Stat software <> version 6.3.6.

      3. StataCorp. Stata statistical software: release 9.0. College Station, TX: Stata Corporation; 2001.

        • Sant M.
        • Allemani C.
        • Santaquilani M.
        • et al.
        • the EUROCARE Working Group
        EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary.
        Eur J Cancer. 2009; 45: 931-991
        • Vercelli M.
        • Quaglia A.
        • Casella C.
        • et al.
        • The EUROCARE Working Group
        Relative survival in elderly cancer patients in Europe.
        Eur J Cancer. 1998; 34: 2264-2270
        • Janssen-Heijnen M.L.G.
        • Gatta G.
        • Forman D.
        • Capocaccia R.
        • Coebergh J.W.W.
        • The EUROCARE Working Group
        Variation in survival of patients with lung in Europe, 1985–1989.
        Eur J Cancer. 1998; 34: 2191-2196
        • Wisnivesky J.P.
        • Halm E.A.
        Sex differences in lung cancer survival: do tumors behave differently in elderly women?.
        J Clin Oncol. 2007; 25: 1705-1712
        • Berrino F.
        • Gatta G.
        • The EUROCARE Working Group
        Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours.
        Eur J Cancer. 1998; 34: 2154-2161
        • Faivre J.
        • Forman D.
        • Esteve J.
        • Gatta G.
        • The EUROCARE Working Group
        Survival of patients with oesophageal and gastric cancers in Europe.
        Eur J Cancer. 1998; 34: 2167-2175
        • Storm H.H.
        • The EUROCARE Working Group
        Survival of adult patients with cancer of soft tissue or bone in Europe.
        Eur J Cancer. 1998; 34: 2212-2217
        • Sant M.
        • van der Sanden G.
        • Capocaccia R.
        • The EUROCARE Working Group
        Survival rates for primary malignant brain tumours in Europe.
        Eur J Cancer. 1998; 34: 2241-2247
        • Carli P.M.
        • Coebergh J.W.W.
        • Verdecchia A.
        • The EUROCARE Working Group
        Variation in survival of adult patients with haematological malignancies in Europe since 1978.
        Eur J Cancer. 1998; 34: 2253-2263
        • Miller J.G.
        • MacNeil S.
        Gender and cutaneous melanoma.
        Br J Dermatology. 1997; 136: 657-665
        • Adami H.O.
        • Bergstrom R.
        • et al.
        The effect of female sex hormones on cancer survival: a register-based study in patients younger than 20 years at diagnosis.
        JAMA. 1990; : 2189-2193
        • Faivre J.
        • Forman D.
        • Esteve J.
        • Obradovic M.
        • Sant M.
        • The EUROCARE Working Group
        Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe.
        Eur J Cancer. 1998; 34: 2184-2190